Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tampa General Medical Group
Tampa, Florida, United States
- Indiana University
Indianapolis, Indiana, United States
- the Ohio State University Wexner Medical Center
Columbus, Ohio, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Baylor University Medical Center
Dallas, Texas, United States
- Virginia Commonwealth University Medical Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Mar 2017
- Primary completion
- 17 Jul 2018
- Completion
- 17 Jul 2018
- Last update posted
- 19 Jan 2022
- Registered enrollment
- 30
- Registry id
- NCT02802228
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.